Liver: Purified A1AT holds promise as therapy for acute liver failure

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 3, 2014, Pages 140-

  Ray, Katrina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CASPASE 3; CASPASE 8; TUMOR NECROSIS FACTOR;

ACUTE LIVER FAILURE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; DISEASE SEVERITY; DRUG TOLERABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; LIVER PROTECTION; LIVER TRANSPLANTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SURVIVAL; DRUG MECHANISM; DRUG RESPONSE; SURVIVAL TIME;

ALPHA 1-ANTITRYPSIN; ANIMALS; DRUG-INDUCED LIVER INJURY; FEMALE; LIVER FAILURE, ACUTE; SERINE PROTEINASE INHIBITORS;

EID: 84895924684     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.16     Document Type: Note

References (1)

1. Original article Jedicke, N. et al. Alpha-1-antitrypsin inhibits acute liver failure in mice. Hepatology doi:10.1002/hep.27024